• |
Record H1 revenues exceed full-year 2024 levels; Q2 cash burn[1] at ~$7.3M; reiterating 2025 revenue guidance; raising NRE bookings targets
|
• |
Development agreement with Top 5 passenger OEM reinforces Innoviz’s position as a preferred technology partner for global OEMs
|
• |
Supporting increasing demand from new and existing customers; shipped first units from Fabrinet’s high-volume production line
|
• |
SODW with Top 5 Automotive OEM – signed a Statement of
Development Work (SODW) agreement with a Top 5 passenger automotive OEM.
|
• |
First units shipping from Fabrinet – to support our customers
across L3, L4, and non-automotive applications, we have begun shipping units from Fabrinet’s high-volume production line.
|
• |
Launched InnovizSMART – announced the launch of InnovizSMART,
which brings auto-grade LiDAR to industrial applications such as Security, Mobility, Aerial, Robotics, and Traffic Management.
|
• |
Announced key collaborations with Cogniteam, Sparsh CCTV, CronAI and
integration with NVIDIA Jetson Orin platform – shortly after unveiling InnovizSMART, Innoviz announced collaborations with multiple companies to develop a variety of solutions for deployment in areas such as safety, security, and
others.
|
• |
Revenues of $50-$60 million, more than 2x 2024 levels;
|
• |
1-3 new program wins
|
• |
The company is raising its 2025 NRE bookings target to $30-$60 million from $20-$50 million. Year to date, Innoviz has booked over $20 million in NREs.
|
INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS |
U.S. dollars in thousands (except share and per share data)
(Unaudited) |
Six Months Ended
June 30,
|
Three Months Ended
June 30,
|
|||||||||||||||
2025
|
2024
|
2025
|
2024
|
|||||||||||||
Revenues
|
$
|
27,137
|
$
|
13,721
|
$
|
9,747
|
$
|
6,664
|
||||||||
Cost of revenues
|
(18,595
|
)
|
(15,255
|
)
|
(8,187
|
)
|
(6,901
|
)
|
||||||||
Gross profit (loss)
|
8,542
|
(1,534
|
)
|
1,560
|
(237
|
)
|
||||||||||
Operating expenses:
|
||||||||||||||||
Research and development
|
27,982
|
40,606
|
13,152
|
16,761
|
||||||||||||
Sales and marketing
|
2,891
|
4,116
|
1,170
|
1,716
|
||||||||||||
General and administrative
|
8,676
|
10,233
|
4,221
|
4,789
|
||||||||||||
Total operating
expenses
|
39,549
|
54,955
|
18,543
|
23,266
|
||||||||||||
Operating loss
|
(31,007
|
)
|
(56,489
|
)
|
(16,983
|
)
|
(23,503
|
)
|
||||||||
Financial income (expense), net
|
(29
|
)
|
5,261
|
(1,445
|
)
|
2,360
|
||||||||||
Loss before taxes on income
|
(31,036
|
)
|
(51,228
|
)
|
(18,428
|
)
|
(21,143
|
)
|
||||||||
Taxes on income
|
(85
|
)
|
(77
|
)
|
(51
|
)
|
(24
|
)
|
||||||||
Net loss
|
$
|
(31,121
|
)
|
$
|
(51,305
|
)
|
$
|
(18,479
|
)
|
$
|
(21,167
|
)
|
||||
Basic and diluted net loss per ordinary share
|
$
|
(0.16
|
)
|
$
|
(0.31
|
)
|
$
|
(0.09
|
)
|
$
|
(0.13
|
)
|
||||
Weighted average number of ordinary shares used in
computing basic and diluted net loss per ordinary share |
192,642,299
|
166,095,197
|
200,079,493
|
166,530,895
|
INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS |
U.S.
dollars in thousands
(Unaudited) |
June 30,
|
December 31,
|
|||||||
2025
|
2024
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
13,535
|
$
|
25,365
|
||||
Short-term restricted cash
|
16
|
16
|
||||||
Bank deposits
|
56,574
|
30,628
|
||||||
Marketable securities
|
9,270
|
11,955
|
||||||
Trade receivables, net
|
11,623
|
6,043
|
||||||
Inventory
|
3,201
|
1,905
|
||||||
Prepaid expenses and other current assets
|
6,678
|
6,707
|
||||||
Total current assets
|
100,897
|
82,619
|
||||||
LONG-TERM ASSETS:
|
||||||||
Restricted deposits
|
2,897
|
2,725
|
||||||
Property and equipment, net
|
20,752
|
23,432
|
||||||
Operating lease right-of-use assets, net
|
26,469
|
23,194
|
||||||
Other long-term assets
|
90
|
79
|
||||||
Total long-term assets
|
50,208
|
49,430
|
||||||
Total assets
|
$
|
151,105
|
$
|
132,049
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Trade payables
|
$
|
3,346
|
$
|
8,813
|
||||
Deferred revenues
|
3,449
|
274
|
||||||
Employees and payroll accruals
|
9,498
|
8,722
|
||||||
Accrued expenses and other current liabilities
|
6,376
|
5,631
|
||||||
Operating lease liabilities
|
5,635
|
4,330
|
||||||
Total current liabilities
|
28,304
|
27,770
|
||||||
LONG-TERM LIABILITIES:
|
||||||||
Operating lease liabilities
|
29,625
|
25,264
|
||||||
Warrants liability
|
56
|
86
|
||||||
Total long-term liabilities
|
29,681
|
25,350
|
||||||
SHAREHOLDERS’ EQUITY:
|
||||||||
Ordinary Shares of no-par value
|
-
|
-
|
||||||
Additional paid-in capital
|
854,286
|
808,974
|
||||||
Accumulated deficit
|
(761,166
|
)
|
(730,045
|
)
|
||||
Total shareholders’ equity
|
93,120
|
78,929
|
||||||
Total liabilities and shareholders’ equity
|
$
|
151,105
|
$
|
132,049
|
INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS |
U.S. dollars in thousands
(Unaudited) |
Six Months Ended
June 30,
|
Three Months Ended
June 30,
|
|||||||||||||||
2025
|
2024
|
2025
|
2024
|
|||||||||||||
Cash flows from operating activities:
|
||||||||||||||||
Net loss
|
$
|
(31,121
|
)
|
$
|
(51,305
|
)
|
$
|
(18,479
|
)
|
$
|
(21,167
|
)
|
||||
Adjustments required to reconcile net loss to net cash
used in operating activities: |
||||||||||||||||
Depreciation and amortization
|
2,715
|
4,036
|
1,338
|
1,541
|
||||||||||||
Remeasurement of warrants liability
|
(30
|
)
|
(149
|
)
|
18
|
(63
|
)
|
|||||||||
Change in accrued interest on bank deposits
|
(654
|
)
|
(465
|
)
|
(317
|
)
|
322
|
|||||||||
Change in marketable securities
|
(91
|
)
|
(259
|
)
|
(29
|
)
|
(101
|
)
|
||||||||
Share-based compensation
|
7,907
|
11,145
|
3,153
|
4,635
|
||||||||||||
Foreign exchange loss (gain), net
|
(1,283
|
)
|
124
|
(1,437
|
)
|
170
|
||||||||||
Change in prepaid expenses and other assets
|
(131
|
)
|
3,153
|
(2,260
|
)
|
983
|
||||||||||
Change in trade receivables, net
|
(5,580
|
)
|
1,977
|
6,038
|
(5,081
|
)
|
||||||||||
Change in inventory
|
383
|
115
|
182
|
259
|
||||||||||||
Change in operating lease assets and liabilities, net
|
2,391
|
(1,327
|
)
|
3,103
|
(747
|
)
|
||||||||||
Change in trade payables
|
(4,564
|
)
|
(2,247
|
)
|
(987
|
)
|
(180
|
)
|
||||||||
Change in accrued expenses and other liabilities
|
1,049
|
(1,187
|
)
|
526
|
(352
|
)
|
||||||||||
Change in employees and payroll accruals
|
776
|
248
|
622
|
(858
|
)
|
|||||||||||
Change in deferred revenues
|
3,175
|
(6,487
|
)
|
2,231
|
(120
|
)
|
||||||||||
Net cash used in operating activities
|
(25,058
|
)
|
(42,628
|
)
|
(6,298
|
)
|
(20,759
|
)
|
||||||||
Cash flows from investing activities:
|
||||||||||||||||
Purchase of property and equipment
|
(2,924
|
)
|
(2,029
|
)
|
(1,009
|
)
|
(880
|
)
|
||||||||
Proceeds from sales of property and equipment
|
3
|
-
|
3
|
-
|
||||||||||||
Investment in bank deposits
|
(58,700
|
)
|
(15,500
|
)
|
(14,400
|
)
|
(1,500
|
)
|
||||||||
Withdrawal of bank deposits
|
33,450
|
56,000
|
20,950
|
31,000
|
||||||||||||
Investment in restricted deposits
|
-
|
(67
|
)
|
-
|
-
|
|||||||||||
Investment in marketable securities
|
(22,931
|
)
|
(14,795
|
)
|
(8,039
|
)
|
(13,857
|
)
|
||||||||
Proceeds from sales and maturities of marketable securities
|
25,707
|
16,694
|
7,970
|
15,799
|
||||||||||||
Net cash provided by (used in) investing activities
|
(25,395
|
)
|
40,303
|
5,475
|
30,562
|
|||||||||||
Cash flows from financing activities:
|
||||||||||||||||
Issuance of ordinary shares and warrants, net of issuance cost
|
37,289
|
-
|
(307
|
)
|
-
|
|||||||||||
Proceeds from exercise of options
|
265
|
111
|
123
|
69
|
||||||||||||
Net cash provided by (used in) financing activities
|
37,554
|
111
|
(184
|
)
|
69
|
|||||||||||
Effect of exchange rate changes on cash, cash
equivalents and restricted cash |
1,069
|
(43
|
)
|
1,173
|
(117
|
)
|
||||||||||
Increase (decrease) in cash, cash equivalents and
restricted cash |
(11,830
|
)
|
(2,257
|
)
|
166
|
9,755
|
||||||||||
Cash, cash equivalents and restricted cash at the
beginning of the period |
25,381
|
26,336
|
13,385
|
14,324
|
||||||||||||
Cash, cash equivalents and restricted cash at the
end of the period |
$
|
13,551
|
$
|
24,079
|
$
|
13,551
|
$
|
24,079
|